Surprisingly, the anti-PD1 mAb, 609A, in the presence of PBMCs did not enhance the killing of PDL1-overexpressing tumor cells (N87-PDL1) compared to that of PBMCs alone. The gene discussed is CD274; the disease is neoplasm.